Cipla Limited (CIPLA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.041x

Based on the latest financial reports, Cipla Limited (CIPLA) has a cash flow conversion efficiency ratio of 0.041x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs13.45 Billion ≈ $145.49 Million USD) by net assets (Rs330.25 Billion ≈ $3.57 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CIPLA net asset quality index to measure how much of total assets are equity-financed.

Cipla Limited - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Cipla Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Cipla Limited's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Cipla Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cipla Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
AKESO INC. O.N.
F:4RY
N/A
Exelixis Inc
NASDAQ:EXEL
0.154x
NIPPON YUSEN K.K.SP.DR1/5
F:NYK
N/A
Revvity Inc.
NYSE:RVTY
0.016x
BANKINTER ADR 2007 EO-30
F:BAK
N/A
Tyler Technologies Inc
NYSE:TYL
0.030x
Dongfang Electric Corp Ltd Class A
SHG:600875
-0.065x
Taiwan Union Technology
TWO:6274
-0.087x

Annual Cash Flow Conversion Efficiency for Cipla Limited (2004–2025)

The table below shows the annual cash flow conversion efficiency of Cipla Limited from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Cipla Limited.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs312.89 Billion
≈ $3.38 Billion
Rs50.05 Billion
≈ $541.27 Million
0.160x +3.71%
2024-03-31 Rs268.03 Billion
≈ $2.90 Billion
Rs41.34 Billion
≈ $447.07 Million
0.154x +12.97%
2023-03-31 Rs237.14 Billion
≈ $2.56 Billion
Rs32.38 Billion
≈ $350.14 Million
0.137x -13.31%
2022-03-31 Rs211.17 Billion
≈ $2.28 Billion
Rs33.26 Billion
≈ $359.68 Million
0.157x -22.05%
2021-03-31 Rs185.86 Billion
≈ $2.01 Billion
Rs37.55 Billion
≈ $406.11 Million
0.202x +5.73%
2020-03-31 Rs160.57 Billion
≈ $1.74 Billion
Rs30.68 Billion
≈ $331.84 Million
0.191x +73.39%
2019-03-31 Rs153.44 Billion
≈ $1.66 Billion
Rs16.91 Billion
≈ $182.89 Million
0.110x +9.87%
2018-03-31 Rs145.82 Billion
≈ $1.58 Billion
Rs14.63 Billion
≈ $158.19 Million
0.100x -45.32%
2017-03-31 Rs129.82 Billion
≈ $1.40 Billion
Rs23.82 Billion
≈ $257.58 Million
0.183x +25.06%
2016-03-31 Rs118.66 Billion
≈ $1.28 Billion
Rs17.41 Billion
≈ $188.26 Million
0.147x +37.30%
2015-03-31 Rs109.82 Billion
≈ $1.19 Billion
Rs11.73 Billion
≈ $126.90 Million
0.107x -40.73%
2014-03-31 Rs86.68 Billion
≈ $937.38 Million
Rs15.63 Billion
≈ $169.00 Million
0.180x +16.34%
2013-03-31 Rs90.19 Billion
≈ $975.34 Million
Rs13.98 Billion
≈ $151.15 Million
0.155x -30.88%
2012-03-31 Rs76.38 Billion
≈ $826.07 Million
Rs17.13 Billion
≈ $185.23 Million
0.224x +45.08%
2011-03-31 Rs66.33 Billion
≈ $717.29 Million
Rs10.25 Billion
≈ $110.86 Million
0.155x -12.42%
2010-03-31 Rs59.11 Billion
≈ $639.21 Million
Rs10.43 Billion
≈ $112.80 Million
0.176x +104.69%
2009-03-31 Rs43.48 Billion
≈ $470.20 Million
Rs3.75 Billion
≈ $40.54 Million
0.086x -11.79%
2008-03-31 Rs37.55 Billion
≈ $406.11 Million
Rs3.67 Billion
≈ $39.69 Million
0.098x -5.42%
2007-03-31 Rs32.36 Billion
≈ $349.99 Million
Rs3.34 Billion
≈ $36.17 Million
0.103x -26.06%
2006-03-31 Rs19.83 Billion
≈ $214.48 Million
Rs2.77 Billion
≈ $29.97 Million
0.140x +8.56%
2005-03-31 Rs15.54 Billion
≈ $168.02 Million
Rs2.00 Billion
≈ $21.63 Million
0.129x -35.24%
2004-03-31 Rs12.64 Billion
≈ $136.70 Million
Rs2.51 Billion
≈ $27.17 Million
0.199x --

About Cipla Limited

NSE:CIPLA India Drug Manufacturers - Specialty & Generic
Market Cap
$12.17 Billion
Rs1.13 Trillion INR
Market Cap Rank
#1920 Global
#72 in India
Share Price
Rs1393.00
Change (1 day)
-1.56%
52-Week Range
Rs1192.40 - Rs1663.60
All Time High
Rs1683.00
About

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, suc… Read more